Fujifilm Announces Financial Results for the Fiscal Year Ended March 31, 2026

• 16 hours ago

Fujifilm Announces Financial Results for the Fiscal Year Ended March 31, 2026

TOKYO, May 12, 2026 – FUJIFILM Holdings Corporation announced today financial results for the full-year of fiscal year ended March 31, 2026.

Full-Year Results for the Fiscal Year Ended March 31, 2026

• Revenue was JPY3,357.0 billion and increased 5.0% year-over-year.
• Operating income was JPY350.2 billion and increased 6.1% year‑over‑year.
• Net income attributable to FUJIFILM Holdings was JPY276.7 billion and increased 6.0% year‑over‑year.
• The annual dividend for FY2025 is expected to be JPY70 per share, marking the 16th consecutive annual increase.

Outlook for Fiscal Year Ending March 2027

• For the fiscal year ending March 2027, the company projects record high financial performance, with revenue of JPY3.47 trillion, supported by the expanded operation of large-scale Bio CDMO facilities and increased sales of semiconductor materials.
• Operating income is expected to rise 4.2% year-on-year to JPY365.0 billion, reflecting strong performance in the Electronics and Imaging segments.
• Net income attributable to FUJIFILM Holdings is forecasted at JPY280.0 billion.
• This outlook does not incorporate the potential impact of fluctuations in raw material prices and energy costs associated with heightened geopolitical tensions in the Middle East, given the significant uncertainty surrounding future developments.
• The annual dividend for the fiscal year ending March 2027 is forecasted at JPY75 per share, marking the company’s 17th consecutive annual dividend increase.

“We achieved record-high revenue, operating income, and net income, driven by strong performance in the Healthcare segment supported by the operation of new Bio CDMO facilities, solid results in semiconductor materials within the Electronics segment, and steady growth in the Imaging segment, including digital cameras.” said Teiichi Goto, president and chief executive officer, representative director, FUJIFILM Holdings Corporation. “In this current fiscal year, our focus is on achieving sustainable growth by expanding our semiconductor materials business and scaling production capacity in the Bio CDMO business. We are committed to accelerating progress toward the goals outlined in VISION2030 and establishing Fujifilm as a collection of global leading businesses.”

Fourth-quarter financial highlights from January to March by business segments

In the fourth quarter, revenue increased by 6.8% year-over-year to JPY927.3 billion. Operating income was JPY101.8 billion, representing a 4.8% year-over-year decrease. Net income attributable to FUJIFILM Holdings increased by 5.0% year-over-year to JPY83.4 billion.

Healthcare

• Revenue increased by 5.4% year-over-year to JPY333.6 billion, while operating income declined by 34.7% year-over-year to JPY29.7 billion, primarily due to the higher raw material costs due to surging silver prices.
• In the Medical Systems business, strong sales of endoscopes across major markets, including the United States and Europe, together with concentrated deliveries from large-scale contracts, resulted in an approximate 30% increase in sales, contributing to revenue growth.
• The Bio CDMO business recorded higher revenue, supported by the operation of new facilities at the Denmark site, while the LS Solutions business also achieved revenue growth as the market for cell culture media continued to recover.

Electronics

• Revenue increased by 27.4% year-over-year to JPY127.5 billion, and operating income rose by 74.0% year-over-year to JPY30.7 billion.
• In the Electronic Materials business, revenue increased by 29.3% year-over-year, driven by strong demand for advanced semiconductor materials used in generative AI.
• In the Advanced Functional Materials business, revenue increased by 24.1% year-over-year, supported by strong sales of display materials as well as increased sales of large capacity data tapes for major IT companies.

Business Innovation

• Revenue decreased by 3.5% year-over-year to JPY324.8 billion, and operating income declined by 15.4% year-over-year to JPY27.0 billion.
• In the Business Solutions business, revenue growth was primarily driven by the expansion of solutions related to digital transformation.
• In the Office Solutions business, revenue declined due to sluggish market conditions in the Asia-Pacific region and the strategic streamlining of low-margin product offerings.
• In the Graphic Communications business, revenue remained largely flat, as increased sales of xerographic equipment in new markets were offset by reduced demand for printing plates and related products in Europe amid weak market conditions.

Imaging

• Strong sales of instant photo systems and digital cameras drove revenue up by 22.6% year-over-year to JPY141.4 billion, while operating income increased by 1.1% year-over-year to JPY24.5 billion.
• In the Consumer Imaging business, steady sales growth of core instax^™ models such as the instax mini 12^™ and instax mini Evo^™, as well as solid sales of products including the instax WIDE 400^™, instax Link 3^™, and instax WIDE Evo^™, contributed to revenue growth by expanding the user base.
• In the Professional Imaging business, strong performance of models launched during the current fiscal year, including the GFX100RF, X half, X‑E5, and X‑T30 III, together with continued sales of existing models, supported overall revenue growth.

via Fujifilm